TRF2 inhibition promotes anchorage-independent growth of telomerase-positive human fibroblasts

Although telomere instability is observed in human tumors and is associated with the development of cancers in mice, it has yet to be established that it can contribute to the malignant transformation of human cells. We show here that in checkpoint-compromised telomerase-positive human fibroblasts a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oncogene Jg. 25; H. 7; S. 990 - 997
Hauptverfasser: Brunori, M, Mathieu, N, Ricoul, M, Bauwens, S, Koering, C E, Roborel de Climens, A, Belleville, A, Wang, Q, Puisieux, I, Décimo, D, Puisieux, A, Sabatier, L, Gilson, E
Format: Journal Article
Sprache:Englisch
Veröffentlicht: London Nature Publishing Group UK 16.02.2006
Nature Publishing
Nature Publishing Group
Nature Publishing Group [1987-....]
Schlagworte:
ISSN:0950-9232, 1476-5594
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Abstract Although telomere instability is observed in human tumors and is associated with the development of cancers in mice, it has yet to be established that it can contribute to the malignant transformation of human cells. We show here that in checkpoint-compromised telomerase-positive human fibroblasts an episode of TRF2 inhibition promotes heritable changes that increase the ability to grow in soft agar, but not tumor growth in nude mice. This transforming activity is associated to a burst of telomere instability but is independent of an altered control of telomere length. Moreover, it cannot be recapitulated by an increase in chromosome breaks induced by an exposure to γ -radiations. Since it can be revealed in the context of telomerase-proficient human cells, telomere dysfunction might contribute to cancer progression even at late stages of the oncogenesis process, after the telomerase reactivation step.
AbstractList Although telomere instability is observed in human tumors and is associated with the development of cancers in mice, it has yet to be established that it can contribute to the malignant transformation of human cells. We show here that in checkpoint-compromised telomerase-positive human fibroblasts an episode of TRF2 inhibition promotes heritable changes that increase the ability to grow in soft agar, but not tumor growth in nude mice. This transforming activity is associated to a burst of telomere instability but is independent of an altered control of telomere length. Moreover, it cannot be recapitulated by an increase in chromosome breaks induced by an exposure to γ -radiations. Since it can be revealed in the context of telomerase-proficient human cells, telomere dysfunction might contribute to cancer progression even at late stages of the oncogenesis process, after the telomerase reactivation step.
Although telomere instability is observed in human tumors and is associated with the development of cancers in mice, it has yet to be established that it can contribute to the malignant transformation of human cells. We show here that in checkpoint-compromised telomerase-positive human fibroblasts an episode of TRF2 inhibition promotes heritable changes that increase the ability to grow in soft agar, but not tumor growth in nude mice. This transforming activity is associated to a burst of telomere instability but is independent of an altered control of telomere length. Moreover, it cannot be recapitulated by an increase in chromosome breaks induced by an exposure to γ-radiations. Since it can be revealed in the context of telomerase-proficient human cells, telomere dysfunction might contribute to cancer progression even at late stages of the oncogenesis process, after the telomerase reactivation step.
Although telomere instability is observed in human tumors and is associated with the development of cancers in mice, it has yet to be established that it can contribute to the malignant transformation of human cells. We show here that in checkpoint-compromised telomerase-positive human fibroblasts an episode of TRF2 inhibition promotes heritable changes that increase the ability to grow in soft agar, but not tumor growth in nude mice. This transforming activity is associated to a burst of telomere instability but is independent of an altered control of telomere length. Moreover, it cannot be recapitulated by an increase in chromosome breaks induced by an exposure to g-radiations. Since it can be revealed in the context of telomerase-proficient human cells, telomere dysfunction might contribute to cancer progression even at late stages of the oncogenesis process, after the telomerase reactivation step.Oncogene (2006) 25, 990-997. doi:10.1038/sj.onc.1209135; published online 3 October 2005
Although telomere instability is observed in human tumors and is associated with the development of cancers in mice, it has yet to be established that it can contribute to the malignant transformation of human cells. We show here that in checkpoint-compromised telomerase-positive human fibroblasts an episode of TRF2 inhibition promotes heritable changes that increase the ability to grow in soft agar, but not tumor growth in nude mice. This transforming activity is associated to a burst of telomere instability but is independent of an altered control of telomere length. Moreover, it cannot be recapitulated by an increase in chromosome breaks induced by an exposure to [italic gamma]-radiations. Since it can be revealed in the context of telomerase-proficient human cells, telomere dysfunction might contribute to cancer progression even at late stages of the oncogenesis process, after the telomerase reactivation step.
Although telomere instability is observed in human tumors and is associated with the development of cancers in mice, it has yet to be established that it can contribute to the malignant transformation of human cells. We show here that in checkpoint-compromised telomerase-positive human fibroblasts an episode of TRF2 inhibition promotes heritable changes that increase the ability to grow in soft agar, but not tumor growth in nude mice. This transforming activity is associated to a burst of telomere instability but is independent of an altered control of telomere length. Moreover, it cannot be recapitulated by an increase in chromosome breaks induced by an exposure to [gamma]-radiations. Since it can be revealed in the context of telomerase-proficient human cells, telomere dysfunction might contribute to cancer progression even at late stages of the oncogenesis process, after the telomerase reactivation step.
Although telomere instability is observed in human tumors and is associated with the development of cancers in mice, it has yet to be established that it can contribute to the malignant transformation of human cells. We show here that in checkpoint-compromised telomerase-positive human fibroblasts an episode of TRF2 inhibition promotes heritable changes that increase the ability to grow in soft agar, but not tumor growth in nude mice. This transforming activity is associated to a burst of telomere instability but is independent of an altered control of telomere length. Moreover, it cannot be recapitulated by an increase in chromosome breaks induced by an exposure to gamma-radiations. Since it can be revealed in the context of telomerase-proficient human cells, telomere dysfunction might contribute to cancer progression even at late stages of the oncogenesis process, after the telomerase reactivation step.Although telomere instability is observed in human tumors and is associated with the development of cancers in mice, it has yet to be established that it can contribute to the malignant transformation of human cells. We show here that in checkpoint-compromised telomerase-positive human fibroblasts an episode of TRF2 inhibition promotes heritable changes that increase the ability to grow in soft agar, but not tumor growth in nude mice. This transforming activity is associated to a burst of telomere instability but is independent of an altered control of telomere length. Moreover, it cannot be recapitulated by an increase in chromosome breaks induced by an exposure to gamma-radiations. Since it can be revealed in the context of telomerase-proficient human cells, telomere dysfunction might contribute to cancer progression even at late stages of the oncogenesis process, after the telomerase reactivation step.
Audience Academic
Author Ricoul, M
Belleville, A
Sabatier, L
Gilson, E
Décimo, D
Koering, C E
Roborel de Climens, A
Mathieu, N
Puisieux, A
Puisieux, I
Wang, Q
Brunori, M
Bauwens, S
Author_xml – sequence: 1
  givenname: M
  surname: Brunori
  fullname: Brunori, M
  organization: Laboratoire de Biologie Moléculaire de la Cellule of Ecole Normale Supérieure de Lyon, UMR CNRS/INRA/ENS
– sequence: 2
  givenname: N
  surname: Mathieu
  fullname: Mathieu, N
  organization: CEA, Commissariat a l’Energie Atomique, Laboratoire de Radiobiologie et Oncologie
– sequence: 3
  givenname: M
  surname: Ricoul
  fullname: Ricoul, M
  organization: CEA, Commissariat a l’Energie Atomique, Laboratoire de Radiobiologie et Oncologie
– sequence: 4
  givenname: S
  surname: Bauwens
  fullname: Bauwens, S
  organization: Laboratoire de Biologie Moléculaire de la Cellule of Ecole Normale Supérieure de Lyon, UMR CNRS/INRA/ENS, Unité d'Oncologie Moléculaire, Unité INSERM 590, Centre Léon Bérard
– sequence: 5
  givenname: C E
  surname: Koering
  fullname: Koering, C E
  organization: Laboratoire de Biologie Moléculaire de la Cellule of Ecole Normale Supérieure de Lyon, UMR CNRS/INRA/ENS
– sequence: 6
  givenname: A
  surname: Roborel de Climens
  fullname: Roborel de Climens, A
  organization: Laboratoire de Biologie Moléculaire de la Cellule of Ecole Normale Supérieure de Lyon, UMR CNRS/INRA/ENS
– sequence: 7
  givenname: A
  surname: Belleville
  fullname: Belleville, A
  organization: Laboratoire de Biologie Moléculaire de la Cellule of Ecole Normale Supérieure de Lyon, UMR CNRS/INRA/ENS, Tumor Biology Unit, Centre Hospitalier Lyon-Sud
– sequence: 8
  givenname: Q
  surname: Wang
  fullname: Wang, Q
  organization: Unité d'Oncologie Moléculaire, Unité INSERM 590, Centre Léon Bérard
– sequence: 9
  givenname: I
  surname: Puisieux
  fullname: Puisieux, I
  organization: Unité d'Oncologie Moléculaire, Unité INSERM 590, Centre Léon Bérard
– sequence: 10
  givenname: D
  surname: Décimo
  fullname: Décimo, D
  organization: Laboratory of Human Virology of Ecole Normale Supérieure de Lyon, INSERM/ENS
– sequence: 11
  givenname: A
  surname: Puisieux
  fullname: Puisieux, A
  organization: Unité d'Oncologie Moléculaire, Unité INSERM 590, Centre Léon Bérard
– sequence: 12
  givenname: L
  surname: Sabatier
  fullname: Sabatier, L
  organization: CEA, Commissariat a l’Energie Atomique, Laboratoire de Radiobiologie et Oncologie
– sequence: 13
  givenname: E
  surname: Gilson
  fullname: Gilson, E
  email: Eric.Gilson@ens-lyon.fr
  organization: Laboratoire de Biologie Moléculaire de la Cellule of Ecole Normale Supérieure de Lyon, UMR CNRS/INRA/ENS, Tumor Biology Unit, Centre Hospitalier Lyon-Sud
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=17508813$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/16205637$$D View this record in MEDLINE/PubMed
https://hal.inrae.fr/hal-02655759$$DView record in HAL
BookMark eNqFkt1rFDEUxYNU7Lb66qMMFgUfZpvvTB6XYq2wIEh9NWSyd3azzCRrMlvxvzfDri4USgkkcPmdc28u5wKdhRgAobcEzwlmzXXezmNwc0KxJky8QDPClayF0PwMzbAWuNaU0XN0kfMWY6w0pq_QOZEUC8nUDP28_35LKx82vvWjj6HapTjEEXJlg9vEZNdQ-7CCHZQrjNU6xd_jpopdNUIfB0g2Q72LuYgfoNrsBxuqzrcptr3NY36NXna2z_Dm-F6iH7ef72_u6uW3L19vFsvaSaHHGlakxZSsnKXCASUSgOGOAHUdl1LyhjZcTV-UHFTHmdAdU60Gp1nbALPsEn06-G5sb3bJDzb9MdF6c7dYmqmGqRRCCf1ACvvxwJav_tpDHs3gs4O-twHiPhupSstGN8-ClDCGpWLPgkQrJriaHK8egdu4T6FsxlDJCVNEqmnA909SVDGuGJ6s5gdobXswPnRxTNaVs4LBuxKSzpf6QjKqOaZcFMG7o-u-HWD1f0v_slCAD0fAZmf7LpUE-HzilMBNQ9ips0sx5wTdCcFmCqXJW1NCaY6hLAL-SOD8aKe0lZF9_7Ts-iDLxT-sIZ3W8ITiL0Bh840
CODEN ONCNES
CitedBy_id crossref_primary_10_1158_1078_0432_CCR_10_3033
crossref_primary_10_1093_nar_gkw1202
crossref_primary_10_1038_onc_2010_344
crossref_primary_10_1016_j_biochi_2007_07_009
crossref_primary_10_1093_nar_gkp582
crossref_primary_10_1007_s00775_010_0631_4
crossref_primary_10_1016_j_bbadis_2009_01_014
crossref_primary_10_4161_cc_29422
crossref_primary_10_1038_nrc_2015_2
crossref_primary_10_3390_molecules181012500
crossref_primary_10_1038_nsmb1192
crossref_primary_10_1073_pnas_2309621121
crossref_primary_10_2217_17460751_3_6_849
crossref_primary_10_1371_journal_pone_0034386
crossref_primary_10_1172_JCI32461
Cites_doi 10.1101/gad.993902
10.1128/MCB.22.7.2111-2123.2002
10.1038/ng989
10.1073/pnas.211357798
10.1002/j.1460-2075.1992.tb05245.x
10.1016/S0092-8674(00)80761-8
10.1038/ng1409
10.1016/S0959-437X(99)00047-7
10.1016/j.cub.2004.09.075
10.1128/jvi.69.2.1328-1333.1995
10.1128/MCB.22.10.3474-3487.2002
10.1038/ng1506
10.1038/22780
10.1016/j.ccr.2004.07.009
10.1038/sj.onc.1207527
10.1101/gad.828901
10.1002/(SICI)1097-4652(199711)173:2<266::AID-JCP33>3.0.CO;2-B
10.1016/S0092-8674(04)00334-4
10.1038/ng1097-236
10.1146/annurev.genet.34.1.331
10.1093/embo-reports/kvf215
10.1371/journal.pbio.0020240
10.1073/pnas.112515399
10.1093/nar/18.12.3587
10.1038/35020592
10.1093/hmg/5.5.685
10.1016/j.cell.2004.10.011
10.1016/0092-8674(85)90170-9
10.1038/13495
10.1016/S0092-8674(03)00430-6
10.1073/pnas.91.11.5124
10.1016/S0092-8674(03)00550-6
10.1016/j.mrrev.2004.06.003
10.1093/emboj/20.11.2619
10.1016/S0092-8674(00)80932-0
10.1016/S0960-9822(02)01179-X
10.1128/MCB.20.5.1659-1668.2000
10.1093/emboj/cdf433
10.1038/88871
10.1101/gad.1165204
10.1126/science.279.5349.349
10.1126/science.275.5302.986
10.1074/jbc.274.12.7936
10.1016/S0092-8674(00)80762-X
10.1126/science.1062329
10.1038/sj.embor.7400352
10.1126/science.1069523
10.1093/emboj/18.12.3509
10.1038/79089
10.1126/science.283.5406.1321
10.1016/S1097-2765(01)00154-X
10.1038/sj.leu.2403086
10.1016/S0002-9440(10)62233-X
ContentType Journal Article
Copyright Springer Nature Limited 2006
2006 INIST-CNRS
COPYRIGHT 2006 Nature Publishing Group
Copyright Nature Publishing Group Feb 16, 2006
Nature Publishing Group 2006.
Distributed under a Creative Commons Attribution 4.0 International License
Copyright_xml – notice: Springer Nature Limited 2006
– notice: 2006 INIST-CNRS
– notice: COPYRIGHT 2006 Nature Publishing Group
– notice: Copyright Nature Publishing Group Feb 16, 2006
– notice: Nature Publishing Group 2006.
– notice: Distributed under a Creative Commons Attribution 4.0 International License
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7TM
7TO
7U9
7X7
7XB
88A
88E
8AO
8C1
8FD
8FE
8FH
8FI
8FJ
8FK
8G5
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
GUQSH
H94
HCIFZ
K9.
LK8
M0S
M1P
M2O
M7P
MBDVC
P64
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
Q9U
RC3
7X8
1XC
DOI 10.1038/sj.onc.1209135
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Nucleic Acids Abstracts
Oncogenes and Growth Factors Abstracts
Virology and AIDS Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Biology Database (Alumni Edition)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
ProQuest Public Health Database
Technology Research Database
ProQuest SciTech Collection
ProQuest Natural Science Journals
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Research Library
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest : Biological Science Collection journals [unlimited simultaneous users]
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
Research Library Prep (ProQuest)
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
ProQuest Health & Medical Collection
PML(ProQuest Medical Library)
Proquest Research Library
Biological Science Database
Research Library (Corporate)
Biotechnology and BioEngineering Abstracts
ProQuest Central Premium
ProQuest One Academic
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
Genetics Abstracts
MEDLINE - Academic
Hyper Article en Ligne (HAL)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Research Library Prep
ProQuest Central Student
Oncogenes and Growth Factors Abstracts
ProQuest Central Essentials
Nucleic Acids Abstracts
SciTech Premium Collection
ProQuest Central China
ProQuest One Applied & Life Sciences
Health Research Premium Collection
Natural Science Collection
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Virology and AIDS Abstracts
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
Engineering Research Database
ProQuest One Academic
ProQuest One Academic (New)
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
Research Library (Alumni Edition)
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Biology Journals (Alumni Edition)
ProQuest Central
ProQuest Health & Medical Research Collection
Genetics Abstracts
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
AIDS and Cancer Research Abstracts
ProQuest Research Library
ProQuest Public Health
ProQuest Central Basic
ProQuest SciTech Collection
ProQuest Medical Library
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
Research Library Prep
Genetics Abstracts
AIDS and Cancer Research Abstracts

MEDLINE
Research Library Prep
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Biology
Computer Science
EISSN 1476-5594
EndPage 997
ExternalDocumentID oai:HAL:hal-02655759v1
1012935311
A632940245
16205637
17508813
10_1038_sj_onc_1209135
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations France
GeographicLocations_xml – name: France
GroupedDBID ---
-Q-
.55
0R~
123
29N
2WC
36B
39C
3O-
3V.
4.4
406
53G
5RE
7X7
88A
88E
8AO
8C1
8FE
8FH
8FI
8FJ
8G5
8R4
8R5
AANZL
AAYZH
AAZLF
ABAKF
ABAWZ
ABDBF
ABJNI
ABLJU
ABUWG
ABZZP
ACAOD
ACGFO
ACGFS
ACKTT
ACMJI
ACPRK
ACRQY
ACUHS
ACZOJ
ADBBV
ADFRT
ADHDB
AEJRE
AEMSY
AENEX
AEVLU
AEXYK
AFBBN
AFKRA
AFSHS
AGHAI
AGQEE
AHMBA
AHSBF
AJRNO
ALFFA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMYLF
ASPBG
AVWKF
AXYYD
AZFZN
AZQEC
B0M
BBNVY
BENPR
BHPHI
BKKNO
BPHCQ
BVXVI
CAG
CCPQU
COF
CS3
DIK
DNIVK
DPUIP
DU5
DWQXO
E3Z
EAD
EAP
EBC
EBD
EBLON
EBS
EE.
EIOEI
EJD
EMB
EMK
EMOBN
EPL
ESX
F5P
FDQFY
FEDTE
FERAY
FIZPM
FRP
FSGXE
FYUFA
GNUQQ
GUQSH
HCIFZ
HMCUK
HVGLF
HZ~
IAO
IHR
INH
INR
ITC
IWAJR
JSO
JZLTJ
KQ8
L7B
LK8
M0L
M1P
M2O
M7P
N9A
NAO
NQJWS
NXXTH
O9-
OK1
OVD
P2P
PQQKQ
PROAC
PSQYO
Q2X
RNS
RNT
RNTTT
ROL
SNX
SNYQT
SOHCF
SOJ
SRMVM
SV3
SWTZT
TAOOD
TBHMF
TDRGL
TEORI
TR2
TSG
TUS
UDS
UKHRP
W2D
WH7
X7M
~8M
AASML
AATNV
AAYXX
ABBRH
ABDBE
ABFSG
ABRTQ
ACSTC
AEFQL
AEZWR
AFDZB
AFFHD
AFHIU
AHWEU
AIGIU
AIXLP
ATHPR
AYFIA
CITATION
PHGZM
PHGZT
PJZUB
PPXIY
PQGLB
.GJ
70F
AACDK
ABEFU
AFFNX
AILAN
BAWUL
FIGPU
IQODW
LGEZI
LOTEE
NADUK
ZXP
CGR
CUY
CVF
ECM
EIF
NPM
7TM
7TO
7U9
7XB
8FD
8FK
FR3
H94
K9.
MBDVC
P64
PKEHL
PQEST
PQUKI
PRINS
Q9U
RC3
PUEGO
7X8
1XC
ID FETCH-LOGICAL-c659t-ed1b021dca25ce216ee30f1e2cf4666482847209164e7f4359f37b9ec93b8e3a3
IEDL.DBID M7P
ISICitedReferencesCount 20
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000235361000004&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 0950-9232
IngestDate Sat Nov 29 15:01:11 EST 2025
Wed Oct 01 00:01:11 EDT 2025
Sun Sep 28 10:25:11 EDT 2025
Thu Oct 02 17:35:06 EDT 2025
Tue Oct 07 05:30:07 EDT 2025
Fri Oct 03 11:10:47 EDT 2025
Sat Nov 29 10:58:40 EST 2025
Wed Feb 19 01:42:02 EST 2025
Mon Jul 21 09:14:04 EDT 2025
Sat Nov 29 03:40:33 EST 2025
Tue Nov 18 21:35:00 EST 2025
Fri Feb 21 02:38:32 EST 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 7
Keywords malignant transformation
TRF2
telomere
Human
Enzyme
Growth
Malignant transformation
Chromosome
Inhibition
Carcinogenesis
Fibroblast
Telomerase
Telomere
TELOMERE
CANCER
GENOMIQUE
MALIGNANT TRANSFORMATION
Language English
License CC BY 4.0
Distributed under a Creative Commons Attribution 4.0 International License: http://creativecommons.org/licenses/by/4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c659t-ed1b021dca25ce216ee30f1e2cf4666482847209164e7f4359f37b9ec93b8e3a3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0001-5738-6723
0000-0002-9938-3798
OpenAccessLink https://www.nature.com/articles/1209135.pdf
PMID 16205637
PQID 227347308
PQPubID 36330
PageCount 8
ParticipantIDs hal_primary_oai_HAL_hal_02655759v1
proquest_miscellaneous_67666898
proquest_miscellaneous_21330673
proquest_miscellaneous_19735478
proquest_journals_2641371671
proquest_journals_227347308
gale_infotracacademiconefile_A632940245
pubmed_primary_16205637
pascalfrancis_primary_17508813
crossref_primary_10_1038_sj_onc_1209135
crossref_citationtrail_10_1038_sj_onc_1209135
springer_journals_10_1038_sj_onc_1209135
PublicationCentury 2000
PublicationDate 20060216
PublicationDateYYYYMMDD 2006-02-16
PublicationDate_xml – month: 2
  year: 2006
  text: 20060216
  day: 16
PublicationDecade 2000
PublicationPlace London
PublicationPlace_xml – name: London
– name: Basingstoke
– name: England
– name: New York
PublicationTitle Oncogene
PublicationTitleAbbrev Oncogene
PublicationTitleAlternate Oncogene
PublicationYear 2006
Publisher Nature Publishing Group UK
Nature Publishing
Nature Publishing Group
Nature Publishing Group [1987-....]
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing
– name: Nature Publishing Group
– name: Nature Publishing Group [1987-....]
References BF1209135_CR19
BF1209135_CR18
BF1209135_CR51
BF1209135_CR50
BF1209135_CR53
BF1209135_CR52
BF1209135_CR11
BF1209135_CR55
BF1209135_CR10
BF1209135_CR54
BF1209135_CR13
BF1209135_CR57
BF1209135_CR12
BF1209135_CR56
BF1209135_CR15
BF1209135_CR59
BF1209135_CR14
BF1209135_CR58
BF1209135_CR17
BF1209135_CR16
BF1209135_CR40
BF1209135_CR42
BF1209135_CR41
BF1209135_CR44
BF1209135_CR43
BF1209135_CR46
BF1209135_CR45
BF1209135_CR48
BF1209135_CR47
BF1209135_CR49
BF1209135_CR31
BF1209135_CR30
BF1209135_CR33
BF1209135_CR32
BF1209135_CR35
BF1209135_CR34
BF1209135_CR37
BF1209135_CR36
BF1209135_CR39
BF1209135_CR38
BF1209135_CR29
BF1209135_CR1
BF1209135_CR2
BF1209135_CR3
BF1209135_CR4
BF1209135_CR5
BF1209135_CR6
BF1209135_CR7
BF1209135_CR8
BF1209135_CR9
BF1209135_CR20
BF1209135_CR22
BF1209135_CR21
BF1209135_CR24
BF1209135_CR23
BF1209135_CR26
BF1209135_CR25
BF1209135_CR28
BF1209135_CR27
References_xml – ident: BF1209135_CR27
  doi: 10.1101/gad.993902
– ident: BF1209135_CR25
  doi: 10.1128/MCB.22.7.2111-2123.2002
– ident: BF1209135_CR45
  doi: 10.1038/ng989
– ident: BF1209135_CR19
  doi: 10.1073/pnas.211357798
– ident: BF1209135_CR14
  doi: 10.1002/j.1460-2075.1992.tb05245.x
– ident: BF1209135_CR22
  doi: 10.1016/S0092-8674(00)80761-8
– ident: BF1209135_CR11
  doi: 10.1038/ng1409
– ident: BF1209135_CR4
  doi: 10.1016/S0959-437X(99)00047-7
– ident: BF1209135_CR13
  doi: 10.1016/j.cub.2004.09.075
– ident: BF1209135_CR41
– ident: BF1209135_CR18
  doi: 10.1128/jvi.69.2.1328-1333.1995
– ident: BF1209135_CR5
– ident: BF1209135_CR1
  doi: 10.1128/MCB.22.10.3474-3487.2002
– ident: BF1209135_CR9
  doi: 10.1038/ng1506
– ident: BF1209135_CR24
  doi: 10.1038/22780
– ident: BF1209135_CR46
  doi: 10.1016/j.ccr.2004.07.009
– ident: BF1209135_CR58
  doi: 10.1038/sj.onc.1207527
– ident: BF1209135_CR16
  doi: 10.1101/gad.828901
– ident: BF1209135_CR48
  doi: 10.1002/(SICI)1097-4652(199711)173:2<266::AID-JCP33>3.0.CO;2-B
– ident: BF1209135_CR52
  doi: 10.1016/S0092-8674(04)00334-4
– ident: BF1209135_CR7
  doi: 10.1038/ng1097-236
– ident: BF1209135_CR59
– ident: BF1209135_CR40
  doi: 10.1146/annurev.genet.34.1.331
– ident: BF1209135_CR32
  doi: 10.1093/embo-reports/kvf215
– ident: BF1209135_CR29
  doi: 10.1371/journal.pbio.0020240
– ident: BF1209135_CR2
  doi: 10.1073/pnas.112515399
– ident: BF1209135_CR42
  doi: 10.1093/nar/18.12.3587
– ident: BF1209135_CR3
  doi: 10.1038/35020592
– ident: BF1209135_CR33
  doi: 10.1093/hmg/5.5.685
– ident: BF1209135_CR54
  doi: 10.1016/j.cell.2004.10.011
– ident: BF1209135_CR23
  doi: 10.1016/0092-8674(85)90170-9
– ident: BF1209135_CR26
  doi: 10.1038/13495
– ident: BF1209135_CR36
  doi: 10.1016/S0092-8674(03)00430-6
– ident: BF1209135_CR15
  doi: 10.1073/pnas.91.11.5124
– ident: BF1209135_CR39
  doi: 10.1016/S0092-8674(03)00550-6
– ident: BF1209135_CR10
  doi: 10.1016/j.mrrev.2004.06.003
– ident: BF1209135_CR21
  doi: 10.1093/emboj/20.11.2619
– ident: BF1209135_CR53
  doi: 10.1016/S0092-8674(00)80932-0
– ident: BF1209135_CR56
– ident: BF1209135_CR43
– ident: BF1209135_CR50
  doi: 10.1016/S0960-9822(02)01179-X
– ident: BF1209135_CR51
  doi: 10.1128/MCB.20.5.1659-1668.2000
– ident: BF1209135_CR49
  doi: 10.1093/emboj/cdf433
– ident: BF1209135_CR47
  doi: 10.1038/88871
– ident: BF1209135_CR55
  doi: 10.1101/gad.1165204
– ident: BF1209135_CR8
  doi: 10.1126/science.279.5349.349
– ident: BF1209135_CR57
– ident: BF1209135_CR38
  doi: 10.1126/science.275.5302.986
– ident: BF1209135_CR35
  doi: 10.1074/jbc.274.12.7936
– ident: BF1209135_CR12
  doi: 10.1016/S0092-8674(00)80762-X
– ident: BF1209135_CR6
  doi: 10.1126/science.1062329
– ident: BF1209135_CR34
  doi: 10.1038/sj.embor.7400352
– ident: BF1209135_CR30
  doi: 10.1126/science.1069523
– ident: BF1209135_CR37
  doi: 10.1093/emboj/18.12.3509
– ident: BF1209135_CR20
  doi: 10.1038/79089
– ident: BF1209135_CR28
  doi: 10.1126/science.283.5406.1321
– ident: BF1209135_CR17
  doi: 10.1016/S1097-2765(01)00154-X
– ident: BF1209135_CR31
  doi: 10.1038/sj.leu.2403086
– ident: BF1209135_CR44
  doi: 10.1016/S0002-9440(10)62233-X
SSID ssj0007902
Score 1.9365754
Snippet Although telomere instability is observed in human tumors and is associated with the development of cancers in mice, it has yet to be established that it can...
SourceID hal
proquest
gale
pubmed
pascalfrancis
crossref
springer
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 990
SubjectTerms Alleles
Animals
Apoptosis
Biological and medical sciences
Cancer
Cell Biology
Cell Line, Transformed
Cell physiology
Cell transformation and carcinogenesis. Action of oncogenes and antioncogenes
Cell Transformation, Neoplastic - genetics
Cell Transformation, Neoplastic - metabolism
Cells (Biology)
Chromosomes
Computer Science
DNA damage
Female
Fibroblasts
Fibroblasts - enzymology
Fibroblasts - pathology
Fundamental and applied biological sciences. Psychology
Growth
Human Genetics
Humans
Internal Medicine
Life Sciences
Medicine
Medicine & Public Health
Mice
Mice, Nude
Molecular and cellular biology
Mutation
Oncology
original-article
Simian virus 40 - genetics
Telomerase
Telomerase - metabolism
Telomere-binding protein
Telomeres
Telomeric Repeat Binding Protein 2 - antagonists & inhibitors
Telomeric Repeat Binding Protein 2 - genetics
Telomeric Repeat Binding Protein 2 - metabolism
Transfection
TRF2 protein
Tumorigenesis
Tumors
Yeast
Title TRF2 inhibition promotes anchorage-independent growth of telomerase-positive human fibroblasts
URI https://link.springer.com/article/10.1038/sj.onc.1209135
https://www.ncbi.nlm.nih.gov/pubmed/16205637
https://www.proquest.com/docview/227347308
https://www.proquest.com/docview/2641371671
https://www.proquest.com/docview/19735478
https://www.proquest.com/docview/21330673
https://www.proquest.com/docview/67666898
https://hal.inrae.fr/hal-02655759
Volume 25
WOSCitedRecordID wos000235361000004&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVPQU
  databaseName: Biological Science Database (Proquest)
  customDbUrl:
  eissn: 1476-5594
  dateEnd: 20191231
  omitProxy: false
  ssIdentifier: ssj0007902
  issn: 0950-9232
  databaseCode: M7P
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/biologicalscijournals
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl:
  eissn: 1476-5594
  dateEnd: 20191231
  omitProxy: false
  ssIdentifier: ssj0007902
  issn: 0950-9232
  databaseCode: BENPR
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Health & Medical Collection
  customDbUrl:
  eissn: 1476-5594
  dateEnd: 20191231
  omitProxy: false
  ssIdentifier: ssj0007902
  issn: 0950-9232
  databaseCode: 7X7
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Research Library
  customDbUrl:
  eissn: 1476-5594
  dateEnd: 20191231
  omitProxy: false
  ssIdentifier: ssj0007902
  issn: 0950-9232
  databaseCode: M2O
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/pqrl
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Public Health Database
  customDbUrl:
  eissn: 1476-5594
  dateEnd: 20191231
  omitProxy: false
  ssIdentifier: ssj0007902
  issn: 0950-9232
  databaseCode: 8C1
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/publichealth
  providerName: ProQuest
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9MwED_RjS8J8VG-wkaJENJ4MYvtJE6eUKlW7YGVahpSn4gS57J2mpqyZJX47znnq0K0vPASKYnl2L6z_Tvf5X4AH7T0ElemHsvQSclAkR4LM99lrvJS1LEwKdIrsgk1mQSzWThtDtyKJqyyXROrhTrNtTkjP6aNm0sC94p_Xv1khjXKeFcbCo0e7JssCbIK3Zt2K7GqYw4JRTiMgIxokzbK4Li4-pTTBDR_jvKK6m2zKTVLc29uIiMfreKCBiurWS62wdC_XKjVzjR-8r99egqPG0xqD2slegZ3cNmHezVL5a8-PBi1pHB9uH_W-OKfw4-L87GwF8v5IqnCvuxVFdmHhU2dmJNmXSJbdCS7pX1JBn85t_PMLvE6N2dhBbI6ZmyNdsUVaGdkvOcJAfqyeAHfxycXo1PWsDUw7XthyTDlCQGGlATsaRTcR5ROxlHozCUbyQ3MRmiG23dRZYTSwkyqJEQdyiRAGcuXsLfMl_gabOmGPEHEWIWpq1Mv9oOEJzz2fUdoBzMLWCuuSDepzA2jxnVUudRlEBVXEYk3asRrwVFXflUn8dhd0kg_MrObatRx85MCtcvkyYqGvhSha9zVFrwnBemqM1m6T4dfI_OMzFrP8J6uuQWDP_Rn83VlgDGXFhy0mhE1i0cRCZNyiCZJYMHhlred0ljwrntNamA8PfES89si4qGSJlHb7hKCS2Msyt0lfEVSC0Kq41Wt6JvG-4Jgs1QWfGw1f9O87eP65t89OYCH9dGWYNw_hL3y5hbfwl29LhfFzQB6aqaqa0DXYMQHsP_lZDI9p7sz8W1QTfrfflhZPg
linkProvider ProQuest
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1bb9MwFD7axmVIiEu5hY0tQiB4MavtXB8QqgZVp3XVhIa0J0zinKydpqY0Waf9KX4jx7m0QrS87YHXxHIc-zs3-_h8AG-0dGNHJi5LsZ1QgCJdFqaewxzfTVBHwpRIL8km_MEgOD0Nj9fgV3MXxqRVNjqxVNRJps0e-R4Zbi7Juff5p8lPZlijzOlqQ6FRweIQr68oZMs_Hnym9X0rRPfLyX6P1awCTHtuWDBMeEyGLaGBuBoF9xBlO-UodOqQL-8ERmELMqOeg35K3kSYSj8OUYcyDlBGkvpdh1vkRoigTBU8nmt-v8pxJK-lzchxEk2RSBns5ecfMhJ4c1OVl9RyCyNYm4L1ocnEvD-JclqctGLVWOb2_nVkW1rC7sP_bQ4fwYPa57Y7lZA8hjUct-BOxcJ53YLN_Yb0rgV3j-pcgyfw_eRrV9ij8XAUl2lt9qTMXMTcpkkbkuScIRvNSYQL-2yaXRVDO0vtAi8ys9eXI6ty4mZol1yIdjqKDYFPlBf5U_h2I__8DDbG2RhfgC2dkMeIGPlh4ujEjbwg5jGPPK8tdBtTC1gDD6XrUu2GMeRClSkDMlD5uSI4qRpOFrybt59URUpWtzRoU0Z7UY86qi9h0LhMHTDV8aQIHXMcb8FrAuS8O1OFvNfpK_OMwnbX8LrOuAU7f-B18XXfOP5cWrDVIFHVyjFXwpRUIiUQWLC95O0cpBbszl8TDMxJVjTG7DJXPPSlKUS3uoXg0gTDcnULz6dVC0Lq43klWIvBe4LCAulb8L6RtMXwls_ry3__yS5s9k6O-qp_MDjcgnvVNp5g3NuGjWJ6ia_gtp4Vo3y6UyoUG37ctPT9BliFsE0
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1bb9MwFD7aBgwkxKXcwsYWIRC8mNZ2EicPCFUd1aaNakJD2hMhcU7WTlNTmqzT_hq_juNcWiFa3vbAa2I5jv2dm318PoA3WrqxIxOXpdhJKECRLgtSz2GOchPUkTAl0kuyCTUY-KenwfEa_Gruwpi0ykYnloo6ybTZI2-T4eaSnHvF22mdFnG81_80-ckMg5Q5aW3oNCqIHOL1FYVv-ceDPVrrt0L0P5_09lnNMMC05wYFw4THZOQSGpSrUXAPUXZSjkKnDvn1jm-UtyCT6jmoUvIsglSqOEAdyNhHGUnqdx1uKUkoNrfUe4v0ElXlO5IH02HkRImmYKT02_n5h4yE39xa5SXN3MIg1mZhfWiyMu9PopwWKq0YNpa5wH8d35ZWsf_wf57PR_Cg9sXtbiU8j2ENxy24U7FzXrfgbq8hw2vB5pc6B-EJfD_52hf2aDwcxWW6mz0pMxoxt2kChyRRZ8hGc3Lhwj6bZlfF0M5Su8CLzOwB5siqXLkZ2iVHop2OYkPsE-VF_hS-3cg_P4ONcTbGF2BLJ-AxIkYqSByduJHnxzzmked1hO5gagFroBLquoS7YRK5CMtUAumH-XlI0ApraFnwbt5-UhUvWd3SIC80Wo161FF9OYPGZeqDhV1PisAxx_QWvCZwzrsz1cn3u0eheUbhvGv4Xmfcgp0_sLv4ujIBAZcWbDWoDGulmYfClFoi5eBbsL3k7RywFuzOXxMMzAlXNMbsMg95oKQpULe6heDSBMlydQtP0ar5AfXxvBKyxeA9QeGCVBa8b6RuMbzl8_ry33-yC5skdOHRweBwC-5Vu3uCcW8bNorpJb6C23pWjPLpTqlbbPhx08L3G1UsuMM
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=TRF2+inhibition+promotes+anchorage-independent+growth+of+telomerase-positive+human+fibroblasts&rft.jtitle=Oncogene&rft.au=Brunori%2C+M&rft.au=Mathieu%2C+N&rft.au=Ricoul%2C+M&rft.au=Bauwens%2C+S&rft.date=2006-02-16&rft.pub=Nature+Publishing+Group&rft.issn=0950-9232&rft.eissn=1476-5594&rft.volume=25&rft.issue=7&rft.spage=990&rft.epage=997&rft_id=info:doi/10.1038%2Fsj.onc.1209135&rft.externalDBID=HAS_PDF_LINK
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0950-9232&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0950-9232&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0950-9232&client=summon